ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2063

Detection of Inflammatory Arthritis and Musculoskeletal Conditions in a First Nations Community: Results of an Onsite Screening Program

Cheryl Barnabe1, Carrissa Low Horn2, Margaret Kargard2, Stephen Mintsioulis2, Sharon Leclercq3, Dianne P. Mosher4, Hani S. El-Gabalawy5, Tyler White2 and Marvin J. Fritzler6, 1Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 2Siksika Health Services, Siksika, AB, Canada, 3Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 4Med, University of Calgary, Calgary, AB, Canada, 5Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, 6Medicine, University of Calgary, Calgary, AB, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Diagnosis and rheumatic disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: RA and SLE are more severe and at least twice as prevalent in the First Nations population of Canada compared to the Caucasian population. Difficulties in accessing rheumatology care have been previously documented. A collaboration between a Blackfoot community (n= 3,700) and rheumatologists from a nearby urban centre was initiated to enable better consultative services for the Nation’s members, and allow for established rheumatology patients to receive care in their home community. Parallel to this initiative, we established an arthritis screening program, with the primary goal being to identify new cases of inflammatory arthritis (IA) early in the disease course.

Methods: A weekly community-based screening program started in June 2011. Consenting participants undergo a musculoskeletal (MSK) history and examination by a rheumatologist and complete a Health Assessment Questionnaire (HAQ). Serologic testing (rheumatoid factor (RF), antinuclear antibody (ANA), extractable nuclear antigens (ENA), anti-cyclic citrullinated peptide (anti-CCP)) is offered and further investigations initiated as appropriate to confirm a diagnosis. Management is provided in conjunction with primary care providers. We provide here a descriptive summary of the program’s outcomes after 1 year.

Results: 144 individuals have been reviewed (74% female, mean age 52.4 years). Half the cohort have a family history of RA (52%) or SLE (18%). All individuals have at least 1 MSK symptom, and 68% report fatigue. The most common sites of joint pain are the hands (81%), knees (75%), lumbar spine (64%), and shoulders (55%). A primary care provider had been consulted by 72% of the cohort prior to the screening program, with 15% having seen a rheumatologist and 15% an orthopedic surgeon in the past. The median HAQ score was 0.88, the median pain score (0-10 VAS) 5, and the median patient global score 5 (0-10 VAS). Seventeen new cases of rheumatic disease have been diagnosed (10 RA, 3 PsA, 1 JIA, 1 Sjogren Syndrome with arthralgias, 2 crystal arthropathies) and 4 individuals remain under observation. Fourteen patients with established rheumatic diseases (6 RA, 1 PsA, 1 spondyloarthritis, 5 SLE, 1 JIA) have re-engaged in active rheumatology care. OA and/or degenerative disk disease was present in 58% of the participants screened, 42% had soft tissue syndromes, 2% had fibromyalgia and 6% had a neurologic condition causing pain. RF and anti-CCP antibodies were rarely positive; anti-CCP was present in low or medium titres in 4 individuals with either soft tissue syndromes or OA. ANA was positive in 52% of the group, with 28% having titres >1:320. In those with positive ANA, only 5 had a history of SLE, IA or RA.

Conclusion: The screening program has been successful in detecting new cases of early IA and returning established rheumatology patients to active care in this First Nations community. There is a significant burden of OA in the community, and many residents are ANA positive in the absence of apparent connective tissue disorders. These findings highlight the need for a multidisciplinary team of primary care providers, allied health professionals, and specialists to maximize MSK care in the community. Limitations at this early phase include participation bias.


Disclosure:

C. Barnabe,
None;

C. Low Horn,
None;

M. Kargard,
None;

S. Mintsioulis,
None;

S. Leclercq,
None;

D. P. Mosher,
None;

H. S. El-Gabalawy,
None;

T. White,
None;

M. J. Fritzler,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detection-of-inflammatory-arthritis-and-musculoskeletal-conditions-in-a-first-nations-community-results-of-an-onsite-screening-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology